Table 1.
Basic information about the study SNPs.
| RS | Location | Consequence | SYMBOL | Control (MAF) | CAR (MAF) | MR (MAF) | MR + CAR (MAF) | HWE |
| rs2407314 | 8:4220831-4220831 | intron_variant | CSMD1 | 38% | 36% | 29.5% | 34.7% | 0.657 |
| rs6601530 | 8:10813762-10813762 | intron_variant | PINX1 | 37.7% | 36.4% | 41.1% | 39.2% | 0.881 |
| rs11250135 | 8:11420637-11420637 | downstream_gene_variant | FAM167A | 28.4% | 29.6% | 25.9% | 33.3% | 0.607 |
| rs7016717 | 8:77718131-77718131 | intergenic_variant | – | 2.2% | 1.5% | 5.4% | 1.6% | 1 |
| rs2071518 | 8:119423572-119423572 | 3_prime_UTR_variant | CCN3 | 15.9% | 19.2% | 15.2% | 20.7% | 1 |
| rs11781551 | 8:122395852-122395852 | intergenic_variant | – | 21.3% | 21.8% | 27.7% | 21.7% | 1 |
| rs12541595 | 8:124845117-124845117 | Upstream_gene_variant | LINC00964 | 32.8% | 32.4% | 28.6% | 34.3% | 0.874 |
| rs11775334 | 8:10214110-9738012 | intron_variant | MSRA | 41.7% | 49.3% | 48.2% | 44.6% | 0.388 |
| rs2407103 | 8:37094396-37094396 | upstream_gene_variant | SMARCE1P4 | 15.4% | 21.1% | 20.5% | 21.5% | 0.179 |
CAR = carotid artery remodeling, HWE = Hardy–Weinberg equilibrium, MAF = minor allele frequency, MR = myocardial remodeling, MsrA = methionine sulfoxide to methionine, SNP = single nucleotide polymorphism.